Buy Reliance Capital, SRF, Aurobindo Pharma: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Reliance Capital and Reliance Infra had mild corrections and strong rallies yesterday. So it was clear that they have broken out. Reliance Capital is a buy with a stop loss of Rs 400, target of Rs 432.""SRF has nice trend and keeps making higher highs. So, that is a buy with a stop loss of Rs 1,400 and look for targets of Rs 1,465," he said."Aurobindo Pharma is one of the stocks which keeps making again fresh highs, so within the pharmaceutical space, probably the best performer. It is a buy with a stop loss of Rs 810, target of Rs 840.""The pharmaceutical space is doing very well. It is up 0.82 percent. Dr Reddy's seems to have bottomed out. So, today is a good day to buy into Dr Reddy's. Possibly downside is 50 points, upside could be 200 points. UPL has turned around and that is now beginning to move up further, so that is where people should look to buy. Tata Steel is moving higher. In Biocon, the uptrend has restarted. So, several stocks are restarting their uptrends. Overall, if you see agri and pharma together are performing extremely well.""In terms of calls, Mahindra and Mahindra Financial Services is a buy with stop loss of Rs 303, target of Rs 321. HUL, post bad results is moving higher. So, that is buy with a stop loss of Rs 850, target of Rs 890.""SKS Microfinance has been down for four days, so sooner or later, it will resume its rally. That is a buy with a stop loss of Rs 590, target of Rs 630.""The long-term trend is up, short-term trend is now higher, so shorting is a very poor idea unless it is a stock like Just Dial which is kind of collapsing.